Press Releases

Titan Medical Strengthens Robotic Surgery U.S. Patent Portfolio with Grant for Surgical Imaging Technology

Company’s head of intellectual property recognized by Intellectual Asset Management as a global IP strategy leader for fifth consecutive year TORONTO (September 3, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in […]

Titan Medical Announces Common Share Purchase Agreement with Aspire Capital Fund of up to US$35 Million

TORONTO (August 29, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that it has entered into a Common Share Purchase Agreement (the “Agreement”) with Aspire Capital […]

Titan Medical to Present at Upcoming September Investment Conferences

TORONTO (August 27, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that management will present at two investment conferences in September. On September 4, 2019, management […]

Titan Medical Announces Successful Completion of Human Factors Evaluation for its Single-Port Robotic Surgical System, Provides Development and Regulatory Update

TORONTO (August 26, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that the human factors evaluation (“HFE”) required to support its planned Investigational Device Exemption (“IDE”) […]

Titan Medical Announces Successful Completion of Survival Phase of GLP Chronic Procedures with its Single-Port Robotic Surgical System

TORONTO (August 6, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces the successful completion of the chronic procedures performed under Good Laboratory Practice (“GLP”) principles using […]